Salvatore Caponnetto | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Safety and efficacy of cabozantinib for metastatic nonclear renal cell carcinoma: Real-world data from an Italian managed access program	AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS	2019
Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer	FRONTIERS IN ONCOLOGY	2019
Adjuvant chemotherapy in resected colon cancer: when, how and how long?	SURGICAL ONCOLOGY	2019
TK inhibitor pazopanib primes DCs by downregulation of the β-catenin pathway	CANCER IMMUNOLOGY RESEARCH	2018
Cancer immunotherapy in patients with brain metastases	CANCER IMMUNOLOGY, IMMUNOTHERAPY	2018
Burned-out testicular cancer: really a different history?	CASE REPORTS IN ONCOLOGY	2017
Prolactin as a potential early predictive factor in metastatic non-small cell lung cancer patients treated with Nivolumab	ONCOLOGY	2017
Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence	ANNALS OF ONCOLOGY	2017
Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: clinical and immunological data of a phase I/II clinical trial	INTERNATIONAL JOURNAL OF ONCOLOGY	2016
Immunological and clinical impact of cancer stem cells in vulvar cancer: role of CD133/CD24/ABCG2-Expressing Cells	ANTICANCER RESEARCH	2016
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab	SCIENTIFIC REPORTS	2016
P-158Radioembolization (SIRT) as a Consolidation Treatment in Colorectal Liver Metastases after First Line Chemotherapy: Efficacy Safety	ANNALS OF ONCOLOGY	2016
Prolactin as a potential negative predictive factor in metastatic non-small cell lung cancers (NSCLC) patients in treatment with Nivolumab (NIVO)	ANNALS OF ONCOLOGY	2016
The macrophage Galactose-type C-type Lectin (MGL) modulates regulatory T cell functions	PLOS ONE	2015
MGL receptor and immunity: when the ligand can make the difference	JOURNAL OF IMMUNOLOGY RESEARCH	2015
E50Safety and toxicity in elderly patients in treatment for metastatic colon cancer	ANNALS OF ONCOLOGY	2015